Artesunate 60 mg for injection WHOPAR part 5 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 LABELLING

Similar documents
Artesunate 120mg powder for injection (Guilin Pharmaceutical Co., Ltd), MA90 LABELLING. Page 1 of 6

Sulfamethoxazole/Trimethoprim 400mg/80mg Tablets (Micro Labs Ltd), HA598. WHOPAR part 5 July 2017 LABELLING

Artesunate/amodiaquine 100/270 mg WHOPAR part 5 03/2009, version 1.0 (Sanofi-Aventis) MA058 LABELING

Lamivudine Tablets 150 mg (Macleods Pharmaceuticals Ltd), HA424. WHOPAR Part 5 05/2011, version 1.0 LABELLING. Page 1 of 8

Artesunate 60 mg for injection WHOPAR part 3 November 2015 (Guilin Pharmaceutical Co., Ltd.), MA051 PATIENT INFORMATION LEAFLET

Artesunate 60 mg for injection WHOPAR part 3 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 PATIENT INFORMATION LEAFLET

WHOPAR part 5 Suppliers submission of the SRA approved text

Artemether 20mg/lumefantrine 120mg WHOPAR part 5 12/2011 Dispersible tablets (Novartis Pharma AG), MA069 LABELLING. Page 1 of 6

PATIENT INFORMATION LEAFLET

JSC «Olainfarm», Latvia PAS-Na 5.52 g Powder for oral solutions

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

RECONSTITUTION, DOSING AND ADMINISTRATION

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

WHOPAR Part 3 March Zinc (as sulfate monohydrate) 20 mg Tablets (Macleods Pharmaceuticals Ltd), DI005 PACKAGE LEAFLET.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX III LABELLING AND PACKAGE LEAFLET

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Actilyse Cathflo 2 mg, poeder voor oplossing voor injectie en infusie. Alteplase

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. Carmellose sodium

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the patient. Vyxeos 44 mg/100 mg powder for concentrate for solution for infusion daunorubicin and cytarabine

Paul-Ehrlich-Institut DE/V/0022/001/II/023/G Page 1

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Read all of this leaflet carefully before you are given this medicine because it contains important information for you.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/17

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dopamine 40 mg/ml Sterile Concentrate

Tuberculin PPD 100,000 units in 1 ml for Heaf Testing continues to be available.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Human Albumin Biotest 20%, solution for infusion Human albumin

PATIENT INFORMATION LEAFLET

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Artecef 50/Artecef 150 (ARTECEF BV) WHOPAR part 4 09/2008, version 1.0 MA027/028 SUMMARY OF PRODUCT CHARACTERISTICS. Page 1 of 7

Package leaflet: Information for the user. /.../ 50 mg powder and solvent for solution for injection/infusion. melphalan

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/16

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PART 1 B SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET

PATIENT INFORMATION LEAFLET

2. What you need to know before you are given Konakion MM. Package Leaflet: Information for the patient

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

Patient Information Leaflet: Information for users

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER. Variquel 1 mg powder and solvent for solution for injection Terlipressin acetate

Package leaflet: Information for the patient. Zerbaxa 1 g / 0.5 g powder for concentrate for solution for infusion ceftolozane / tazobactam

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)

PART 1.B SPC, LABELLING AND PACKAGE LEAFLET

1. What Octostim Nasal Spray is and what it is used for

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PATIENT INFORMATION LEAFLET

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Ventolin Injection 500 micrograms/ml salbutamol sulfate

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. Pharmalgen Bee Venom Pharmalgen Wasp Venom. 100μg/ml. powder and solvent for solution for injection

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)

Package leaflet: Information for the patient. Konakion MM Ampoules 10mg/ml solution for injection and oral solution Phytomenadione (vitamin K 1 )

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (em-plis-city)

PATIENT INFORMATION LEAFLET

[Version 8, 10/2012] ANNEX I SUMMARY OF PROPOSED PRODUCT CHARACTERISTICS

ANNEX III LABELLING AND PACKAGE LEAFLET

SUMMARY OF PRODUCT CHARACTRISTICS

Package leaflet: Information for the patient. ERWINASE 10,000 Units, Powder for solution for injection

Transcription:

LABELLING 1

PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton (pack of 1 vial and 2 ampoules) 1. NAME OF THE MEDICINAL PRODUCT Artesun * 2. STATEMENT OF ACTIVE SUBSTANCE Each vial contains 60 mg artesunate powder for injection. 3. LIST OF EXCIPIENTS Artesunate powder for injection does not contain any excipients. Solvent (sodium bicarbonate injection) contains sodium bicarbonate and water for injection Diluent (sodium chloride injection) contains sodium chloride and water for injection. 4. PHARMACEUTICAL FORM AND CONTENTS Each box contains 1 vial of Artesunate for injection (60 mg) and 1 ampoule of 1 ml Sodium bicarbonate injection (50mg/ml). and 1 ampoule of 5 ml Sodium chloride injection (9mg/ml) 5. METHOD AND ROUTE OF ADMINISTRATION Intramuscular or intravenous use after reconstitution and dilution Read the patient information leaflet before use. 6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN Keep out of the reach and sight of children. 7. OTHER SPECIAL WARNING(S), IF NECESSARY * Trade names are not prequalified by WHO. This is the national medicines regulatory authority s (NMRA) responsibility. Throughout this WHOPAR the proprietary name is given as an example only. 2

8. EXPIRY DATE 9. SPECIAL STORAGE CONDITIONS Do not store above 30 C. Store in the original container protected from light. Reconstituted and diluted solution should be stored below 30 C and used within 1 hour. 10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE 11. NAME AND ADDRESS OF THE SUPPLIER Guilin Pharmaceutical Co., Ltd. No. 43 Qilidian Road Guilin Guangxi China TEL : + 86 773 3675053 Fax: +86 773 2670530 Manufacture site: No. 43 Qilidian Road, Guilin Guangxi,China 12. WHO REFERENCE NUMBER (PREQUALIFICATION PROGRAMME) MA051 13. MANUFACTURER S BATCH NUMBER 14. (ADVICE ON) GENERAL CLASSIFICATION FOR SUPPLY Medicinal product subject to medical prescription. 15. INSTRUCTIONS ON USE 3

MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Powder vial 1. NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Artesun Artesunate for injection 2. METHOD OF ADMINISTRATION I.M./I.V. USE 3. EXPIRY DATE 4. MANUFACTURER S BATCH NUMBER 5. CONTENTS BY WEIGHT, BY VOLUME, OR BY UNIT 60 mg 6. OTHER Sterile Mfg.: Guilian Pharmaceutical Co., Ltd. 4

MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Solvent ampoule 1. NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Sodium Bicarbonate Injection 2. LIST OF EXCIPIENTS Sodium bicarbonate (50 mg/ ampoule) Water for injections (1 ml/ampoule) 3. PHARMACEUTICAL FORM AND CONTENTS Sodium Bicarbonate Injection 1ml 50mg (50 mg/ml) 4. EXPIRY DATE 5. MANUFACTURER S BATCH NUMBER 5. CONTENTS BY WEIGHT, BY VOLUME, OR BY UNIT 1 ml 6. OTHER Sterile Mfg.: Guilian Pharmaceutical Co., Ltd. 5

MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Diluent ampoule 1. NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Sodium Chloride Injection 2. LIST OF EXCIPIENTS Sodium Chloride (45 mg/ampoule) Water for injections (5 ml/ampoule) 3. PHARMACEUTICAL FORM AND CONTENTS Sodium Chloride Injection 5ml 45mg (9 mg/ml) 4. EXPIRY DATE 5. MANUFACTURER S BATCH NUMBER 5. CONTENTS BY WEIGHT, BY VOLUME, OR BY UNIT 5 ml 6. OTHER Sterile Mfg.: Guilian Pharmaceutical Co., Ltd. 6